This invention relates to indwelling catheters that result in increased fluid flow and catheter strength.
High flow rates through catheters are necessary to maximize the efficiency of medical procedures such as dialysis and the introduction of contrast in so-called “power injection” procedures. Certain catheter designs have been developed to increase flow rates, such as in U.S. Pat. Nos. 7,410,602, 6,595,966, and 6,230,423, each of which is incorporated herein by reference, but there remains a growing need for catheters that can accommodate increased flow rates. There is also a need for very small diameter catheters for positioning in smaller bodily lumens, yet allowing for high flow rates and requiring high mechanical strength.
In one aspect, the present invention includes a catheter that comprises a hub, an elongated conduit, and at least one lumen therein. The lumen includes a proximal lumen section, a distal lumen section, and an intermediate lumen section extending between the proximal and distal lumen sections. In one embodiment, a cross-sectional dimension of the intermediate lumen section is less than a cross-sectional dimension of the distal lumen section. In another embodiment, a cross-sectional dimension of the intermediate lumen section is less than a cross-sectional dimension of the proximal lumen section. In certain embodiments, the lumen tapers from the distal and/or proximal lumen sections to the intermediate lumen section.
In certain embodiments, the elongated conduit of the catheter includes a proximal conduit section, a distal conduit section, and an intermediate conduit section extending between the proximal and distal conduit sections. Each of the proximal, intermediate, and distal conduit sections is characterized by an outer cross-sectional dimension. In some embodiments, the outer cross-sectional dimension of the intermediate conduit section is less than the outer cross-sectional dimensions of either or both of the proximal and/or distal conduit sections.
In certain embodiments, the wall thickness of the elongated conduit is greater at the proximal and/or distal conduit sections than at the intermediate conduit section.
In another aspect, the present invention includes a method of making a catheter of the present invention. In certain embodiments, the method will comprise a process of extrusion in which the plastic drawdown is varied programmatically. In alternate embodiments, an internal pressure may be applied within the lumen of the catheter, which pressure optionally varies from the pressure external to the catheter, to create variation in the outer diameter of the catheter or in the wall thickness.
In the drawings, like reference characters generally refer to the same parts throughout the different views. Also, the drawings are not necessarily to scale, emphasis instead generally being placed upon illustrating the principles of the invention.
The present invention relates to catheters designed for high flow rates and to methods for making and using such catheters. In certain embodiments, the present invention makes use of individual or opposing tapers along an indwelling catheter shaft to impart the catheter with increased durability and improved flow dynamics, both for the overall catheter system and localized at the catheter tip, when compared to conventional catheter devices. For certain applications such as venous access devices, the present invention enables the positioning of the smallest diameter portions of the catheter within small veins, such as in the arm, while allowing for the positioning of a larger catheter diameter portion within the great vessels of the chest, such as the superior vena cava. The designs and methods of the present invention apply equally to single lumen and double (or more) lumen embodiments.
The elongated conduit 130 includes a proximal end 131, a distal end 132, a proximal conduit section 133, an intermediate conduit section 134, and a distal conduit section 135. Each of the conduit sections 133, 134, and 135 is characterized by an outer cross-sectional dimension (e.g., diameter) 163, 164, and 165, respectively. In a preferred embodiment as shown in
In the embodiment of
The embodiment shown in
The lumens 170, 180 are of any suitable shape, as is known in the art. For example, when the catheters of the present invention include two lumens, their shape is preferably D-shaped, as shown in
When in use, the elongated conduit 130 of catheter 100 is implanted into a patient's vascular system, while the hub 120 and connecting portions 110, 111 remain outside of the patient's body. The hub 120 optionally includes one or more suture holes 123, 124 for suturing the catheter 100 to the patient's skin. The proximal ends of the connecting portions 110, 111 include connecting means, such as Luer fittings, to facilitate connection to a fluid source to be delivered into the patient, a pump, a suction source for aspirating fluids from the patient, or the like.
As shown in
Although the present invention is described herein with particular reference to PICCs, it should be recognized that aspects of the invention are equally applicable to other implantable catheter devices, such as dialysis catheters, midline catheters, central venous catheters, and ports.
The elongated conduit of the present invention is made from any suitable material, such as, for example, Polyether urethanes or Polyester urethanes, and preferably Polycarbonate urethanes such as those marketed under the Carbothane® mark by Lubrizol Corporation or the Quadrathane® mark by Biomerics, LLC. In an alternate embodiment, the elongated conduit of the present invention is made from a material that expands from a reduced delivery configuration into an expanded working configuration. For example, the elongated conduit, or just the proximal and/or distal conduit sections and corresponding taper section(s) thereof, may be made from a shape memory or other resilient or expandable polymeric material that is compressed to a small outer cross-sectional delivery dimension, and thereafter expands to an enlarged outer cross-sectional dimension to yield the configuration shown in
The embodiment illustrated in
In the embodiment of
Variations, modifications, and other implementations of what is described herein will occur to those of ordinary skill in the art without departing from the spirit and the scope of the invention as claimed. Accordingly, the invention is to be defined not by the preceding illustrative description but instead by the spirit and scope of the following claims.
Number | Name | Date | Kind |
---|---|---|---|
3042044 | Sheridan | Jul 1962 | A |
3094124 | Birtwell | Jun 1963 | A |
3400714 | Sheridan | Sep 1968 | A |
3438375 | Ericson | Apr 1969 | A |
3978157 | Bottenbruch | Aug 1976 | A |
4054139 | Crossley | Oct 1977 | A |
4142525 | Binard | Mar 1979 | A |
4403983 | Edelman | Sep 1983 | A |
4423740 | Castle | Jan 1984 | A |
4468224 | Enzmann | Aug 1984 | A |
4469483 | Becker | Sep 1984 | A |
4483688 | Akiyama | Nov 1984 | A |
4563180 | Jervis | Jan 1986 | A |
4569673 | Tesi | Feb 1986 | A |
4592920 | Murtfeldt | Jun 1986 | A |
4603152 | Laurin | Jul 1986 | A |
4623327 | Mahurkar | Nov 1986 | A |
4769005 | Ginsburg | Sep 1988 | A |
4902503 | Umemura | Feb 1990 | A |
4944726 | Hilal | Jul 1990 | A |
4999210 | Solomon | Mar 1991 | A |
5019096 | Fox, Jr. | May 1991 | A |
5053023 | Martin | Oct 1991 | A |
5059170 | Cameron | Oct 1991 | A |
5125893 | Dryden | Jun 1992 | A |
5133742 | Pinchuk | Jul 1992 | A |
5151231 | Lambert | Sep 1992 | A |
5205834 | Moorehead | Apr 1993 | A |
5229431 | Pinchuk | Jul 1993 | A |
5249598 | Schmidt | Oct 1993 | A |
5300048 | Drewes, Jr. | Apr 1994 | A |
5374245 | Mahurkar | Dec 1994 | A |
5403291 | Abrahamson | Apr 1995 | A |
5405340 | Fageol | Apr 1995 | A |
5472417 | Martin | Dec 1995 | A |
5509897 | Twardowski | Apr 1996 | A |
5542937 | Chee | Aug 1996 | A |
5569182 | Twardowski | Oct 1996 | A |
5575769 | Vaillancourt | Nov 1996 | A |
5614136 | Pepin | Mar 1997 | A |
5662913 | Capelli | Sep 1997 | A |
5683640 | Miller | Nov 1997 | A |
5725510 | Hartmann | Mar 1998 | A |
5800414 | Cazal | Sep 1998 | A |
5843161 | Solovay | Dec 1998 | A |
5879499 | Corvi | Mar 1999 | A |
5928174 | Gibbins | Jul 1999 | A |
6033393 | Balbierz | Mar 2000 | A |
6093180 | Elsberry | Jul 2000 | A |
6177522 | Brady | Jan 2001 | B1 |
6197846 | Combe | Mar 2001 | B1 |
6200338 | Solomon | Mar 2001 | B1 |
6217566 | Ju | Apr 2001 | B1 |
6227200 | Crump | May 2001 | B1 |
6280423 | Davey | Aug 2001 | B1 |
6315789 | Cragg | Nov 2001 | B1 |
6355858 | Gibbins | Mar 2002 | B1 |
6368658 | Schwarz | Apr 2002 | B1 |
6375637 | Campbell | Apr 2002 | B1 |
6409700 | Siegel, Jr. | Jun 2002 | B1 |
6442415 | Bis | Aug 2002 | B1 |
6446671 | Armenia | Sep 2002 | B2 |
6517520 | Chang | Feb 2003 | B2 |
6530951 | Bates | Mar 2003 | B1 |
6545097 | Pinchuk | Apr 2003 | B2 |
6595966 | Davey | Jul 2003 | B2 |
6605751 | Gibbins | Aug 2003 | B1 |
6663614 | Carter | Dec 2003 | B1 |
6777466 | Eckstein | Aug 2004 | B2 |
6819951 | Patel | Nov 2004 | B2 |
6897349 | Gibbins | May 2005 | B2 |
6938668 | Whicher | Sep 2005 | B2 |
7179849 | Terry | Feb 2007 | B2 |
7264858 | Belliveau | Sep 2007 | B2 |
7410602 | Davey | Aug 2008 | B2 |
7846134 | Nadolski | Dec 2010 | B1 |
20010037065 | Graf | Nov 2001 | A1 |
20020082559 | Chang | Jun 2002 | A1 |
20020091362 | Maginot | Jul 2002 | A1 |
20020156430 | Haarala | Oct 2002 | A1 |
20030065355 | Weber | Apr 2003 | A1 |
20030153983 | Miller | Aug 2003 | A1 |
20030203991 | Schottman | Oct 2003 | A1 |
20040068241 | Fischer | Apr 2004 | A1 |
20040068251 | Chan | Apr 2004 | A1 |
20040068315 | Chandrasekaran | Apr 2004 | A1 |
20040073171 | Rogers | Apr 2004 | A1 |
20040076582 | Dimatteo | Apr 2004 | A1 |
20040131863 | Belliveau | Jul 2004 | A1 |
20040171747 | Zhong | Sep 2004 | A1 |
20040199128 | Morris | Oct 2004 | A1 |
20040199192 | Akahoshi | Oct 2004 | A1 |
20040220534 | Martens | Nov 2004 | A1 |
20040266301 | Vedula | Dec 2004 | A1 |
20050010275 | Sahatjian | Jan 2005 | A1 |
20050013988 | Fu | Jan 2005 | A1 |
20050119724 | Phaneuf | Jun 2005 | A1 |
20050131356 | Ash | Jun 2005 | A1 |
20050182352 | Dimatteo | Aug 2005 | A1 |
20050192546 | Griego | Sep 2005 | A1 |
20050216074 | Sahatjian | Sep 2005 | A1 |
20050234388 | Amos | Oct 2005 | A1 |
20050261636 | Rome | Nov 2005 | A1 |
20050261664 | Rome | Nov 2005 | A1 |
20060004325 | Hamatake | Jan 2006 | A1 |
20060052757 | Fischer, Jr. | Mar 2006 | A1 |
20060189922 | Amarasinghe | Aug 2006 | A1 |
20060264912 | McIntyre | Nov 2006 | A1 |
20070043390 | Neilan | Feb 2007 | A1 |
20070225661 | Ash | Sep 2007 | A1 |
20080009832 | Barron | Jan 2008 | A1 |
20090012481 | Davey | Jan 2009 | A1 |
20120041419 | Blanchard | Feb 2012 | A1 |
Entry |
---|
Asch, “Venous access: options, approaches and issues,” Can. Assoc. Radiol. J., vol. 52, No. 3, pp. 153-164 (2001) 12 pages. |
Herts et al., “Power injection of contrast media using central venous catheters: feasibility, safety, and efficacy,” AJR Am. J. Roentgenol., vol. 176, No. 2, pp. 447-453 (2001) 8 pages. |
Roth et al., “Influence of radiographic contrast media viscosity to flow through coronary angiographic catheters,” Cathet. Cardiovasc. Diagn., vol. 22, No. 4, pp. 290-294 (1991) 5 pages. |
Carlson et al., “Safety considerations in the power injection of contrast media via central venous catheters during computered tomogrphic examinations,” Invest. Radiol., vol. 27, No. 5, p. 337-340 (1992). |
Kaste et al., “Safe use of powr injectors with central and peripheral venous access devices for pediatrict CT,” Pediatr. Radiol., vol. 26, No. 8, pp. 449-501 (1996). |
Herts et al., “Power injection of intravenous contrast material through central venous catheters for CT: in vitro evaluation,” Radiology, vol. 200, No. 3, pp. 731-735 (1996). |
Rivitz et al., “Power injection of peripherally inserted central catheters,” J. Vasc. Interv. Radiol., vol. 8, No. 5, pp. 357-863 (1997). |
Rogalla et al., Safe and easy power injection of contrast material through a central line, Eur. Radiol., vol. 8, No. 1, pp. 148-149 (1998). |
Williamson et al., “Assessing the adequacy of peripherally inserted central catheters for power injection of intravenous contrast agents for CT,” J. Comput. Assist. Tomogr., vol. 25, No. 6, pp. 932-937 (2001). |
Chahoud et al., “Randomized comparison of coronary angiography using 4F catheters: 4F manual versus ‘Acisted’ power injection technique,” Catheter Cardiovasc. Interv., vol. 53, No. 2, pp. 221-224 (2001). |
Walsh et al., “Effect of contrast agent viscosity and injection flow velocity on bolus injection pressures for peripheral venous injection in first-pass myocardial perfusion studies,” Technol. Health Care, vol. 10, No. 1, pp. 57-63 (2002). |
Saito et al., “Diagnostic brachial coronary arteriography using a power-assisted injector and 4 French catheters with new shamps,” J. Invasive Cardiol., vol. 9, No. 7pp. 461-468 (1997). |
Carbothane MSDS from Microspecorporation.com accessed Thursday, Aug. 4, 2011. http://www.microspecorporation.com/materials.php?id=5 (1 page). |
Carbothane MSDS from msds.carboline.com accessed Thursday Aug. 4, 2011. http://msds.carboline.com/website/carbmsds.nsf%28a11%29/87496753746CA5888525705A004343CE8/$file/Carbothane+134+HG+PDS+3-11.pdf (2 pgs.). |
“AgION's Silver Copper Zeolite Okayed by FDA for Food Contact,” AgION Technologies, Inc., http://www.agion-tech.com/NewsDetail.asp?PressID=91, 2 pages (2005). |
“Anatomy and Placement,” http://www.mceus.com/picc/piccanat.html, 2 pages (2005). |
“Application Guide,” Spire Corporation, http://www.spirebiomedical.com/Biomedical/app-guide.html, 3 pgs (2005). |
“Biocompatibles-Advanced Biomedical Polymers”, http://www.pharmaceutical-technology.com/contractors/drug-delivery/biocompatibles, 3 pages (2005). |
“Broviac Catheters, PICC Lines and Other Catheters,” The American Pediatric Surgical Association, http://www.eapsa.org/parents/catheter.htm, 13 pages (2005). |
“Central Venous Catheters,” http://academic.luzerne.edu/nfrusciante/nur204/powerpoints/cvc.pdf, 11 pages (2005). |
“Description of Ion Beam Assisted Deposition Process,” Spire Corporation, http://www.spirebiomedical.com/Biomedical/ionbeam.html, 2 pages (2005). |
“Description of Ion Implantation Process,” Spire Corporation, http://www.spirebiomedical.com/Biomedical/ionimpl.html, 4 pages (2005). |
“Electrically Ionized Metals for the Prevention of Catheter Colonization with Microorganisms,” The University of Texas MD Anderson Cancer Center, Office of Technology Development, http://www.mdanderson.org/departments/techcommerc, 2 pages(2005). |
“FAQ: Electroplating—How It Works,” http://www.finishing.com/faqs/howworks.html, 4 pages (2005). |
“Fighting Infections, Healing Wounds,” AcryMed, Inc., http://www.acrymed.com, 1 page (2005). |
“Flexima(TM) Tight Loop All-Purpose Drainage Catheters,” Boston Scientific Corporation, http://www.bostonscientific.com, 1 page (2005). |
Gibbins, “SilvaGard(TM) Technology Summary,” AcryMed, Inc., http://www.acrymed.com/pdf%20files/bpease-silvgrd.pdf, 8 pages (2006). |
Gibbins et al., “The Role of Antimicrobial Silver Nanotechnology,” Medical Device & Diagnostic Industry, http://www.devicelink.com/mddi/archive/05/08/005.html, 6 pages (2005). |
“Ion Beam Processing (IBP) Technologies-Sector Study,” BDM Federal Inc., prepared for the North American Technology and Industrial Base Organization (NATIBO) 133 pages (1996). |
“Ion-Sight(TM)”, Spire Corporation, http://www.spirebiomedical.com/Biomedical/Ionsight.html, 3 pages (2005). |
Management of a PICC Line (Peripherally Inserted Central Catheter), CancerBACUP http://www.cancerbacup.org.uk/Treatments/Chemotherapy/Linesports/PICCline, 4 pages (2005). |
“New Multifunctional Textiles: Antimicrobial Treatments,” Intelligent Textile Structures—Application, Production & Testing, International Workshop, Thessaloniki, Greece, Amphitheater of Thessaloniki Technology Park, 31 pages (2005). |
Oberst, “Researchers Describe How to Put the ‘Nano’ in Synthetic Polymers,” Cornell Chronicle, http://www.news.cornell.edu/Chronicle/04/6.10.04/CCMR-POP-conf.html, 2 pages (2004). |
“ON-Q C-Bloc Continuous Nerve Block System,” I-Flow Corporation, http://www.iflo.com/prod-ong-classic.php, 4 pages (2005). |
“ON-Q® PainBuster® Post-Op Pain Relief System,” I-Flow Corporation, http://www.iflo.com/prod-ong-classic.php, 7 pages (2005). |
Powers, “Antimicrobial Silver Nanoparticles Eliminate Biofilm Formation on Medical Devices,” NanoBiotech News, vol. 3, No. 30, 2 pages (2005). |
“Process Services,” Spire Corporation, http://www.spirebiomedical.com/Biomedical/process-serv.html, 2 pages (2005). |
Rosenthal, “PICC Line,” University of Illinois Medical Center at Chicago, http://uimc.discoveryhospital.com/main.php?t=enc&id=3017, 2 pages (2005). |
“SilvaGard(TM) Antimicrobial Surface Treatment,” AcryMed, Inc., http://www.acrymed.com/techATD.htm, 2 pages (2005). |
“Silver Catheter Destroys Bacterial Paradise,” NewsDesk No. 9820, Siemens AG, http://w4.siemens.de/en2/html/press/newsdesk-archive/1998/e-9820-d.html, 2 pages (1998). |
Sobie, “Ion Beam Technology for Thin Film Applications,” edited from a reprint of Vacuum & Thinfilm, 6 pages (2001). |
“SPI-Argent(TM),” Spire Corporation, http://www.spirebiomedical.com/Biomedical/SPlargent.html, 2 pages (2005). |
“Tal MicroDrainage(TM) Set,” Boston Scientific Corporation, http://www.bostonscientific.com, 2 pages (2005). |
“Technology Overview,” Spire Corporation, http://www.spirebiomedical.com/Biomedical/techoverview.html, 1 page (2005). |
“Types of CV ADs,” Hemophilia Galaxy, http://www.hemophiliagalaxy.com/patients/managing/va-centralitypes.html, 3 pages (2005). |
“Vaxcel® Implantable Ports with PASV® Valve Technology,” Boston Scientific Corporation, http://www.bostonscientific.com, 3 pages (2005). |
“Vaxcel® Implantable Ports with PASV® Valve Technology-Port Design Options,” Image, Boston Scientific Corporation http://www.bostonscientific.com (2005). |
“Vaxcel® Peripherally Inserted Central Catheter (PICC),” Boston Scientific Corporation, http:www.bostonscientific.com, 3 pages (2005). |
“Vaxcel® Peripherally Inserted Central Catheter (PICC)-Instructions for Use,” Boston Scientific Corporation, http://www.bostonscientific.com, 3 pages (2005). |
“Vaxcel® Peripherally Inserted Central Catheter (PICC)-Product Information” Boston Scientific Corporation, http://www.bostonscientific.com, 3 pages (retrieved from the Internet prior to the filing of the application), Nov. 15, 2005. |
“Vaxcel® Plus Chronic Dialysis Catheter,” Boston Scientific Corporation, http://www.bostonscientific.com, 2 pages (2005). |
“Vaxcel® Tunneled Central Venous Catheter,” Boston Scientific Corporation, http://www.bostonscientific.com, 6 pages (2005). |
“Vaxcel® Tunneled Central Venous Catheters—Product Information,” Boston Scientific Corporation, http://www.bostonscientific.com, 3 pages (retrieved from the Internet prior to filing of the application). |
“Venous Access Device Insertion and Maintenance,” Boston Scientific Corporation, http://www.bostonscientific.com/templatedata/imports/HTML/infusion-therapy/index.html, 1 page (2005). |
Zschaler “Testing of the Antimicrobial Effect of Catheter Tubing with a Roll Culture Method,” 4 pages (2005). |
Hunter et al.“Anti-Scarring Drug Combinations and Use Thereof,” U.S. Appl. No. 60/723,053 Specification (2005). |
J.A. Zawacki, “Carbothane Fixed Split-Tip Dialysis Catheters for Longer-Term Haemodialysis,” Business Briefing: Global Healthcare—Advanced Medical Technologiespp. 1-2 (2004). |
Thermedics Polymer Products, “Committed to Providing Medical Grade Thermoplastic Polyurethane Resins,” http://www.viasys.tv/prod-serv/downloads/139-Brochure.pdf, pp. 1-8 (2005). |
“HemoSplit Catheter, 510(k), Summary of Safety and Effectiveness, 21 CFR 807.92(a),” (2003) 3 pages. |
“Noveon, Medical Urethanes,” http://www.estane.com/technology/Medical.asp, pp. 1-6 (2005). |
“Vaxcel® Plus Chronic Dialysis Catheter,” http://www.bostonscientific.com/med-specialty/deviceDetail.jsp?task=tskBasicDevice.jsp§ionId=4&re1ID=4,178,179,180&deviceId=13015&uniqueId=MPDB3839 (2007). 2 pages. |
T.M. Vesely, “Tunneled Catheter Design: Does it Matter? (Lecture),” The Journal of Vascular Access, vol. 6, pp. 132-136 (2005). |
Number | Date | Country | |
---|---|---|---|
20180256847 A1 | Sep 2018 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 14702856 | May 2015 | US |
Child | 15981424 | US | |
Parent | 13474004 | May 2012 | US |
Child | 14702856 | US | |
Parent | 13053428 | Mar 2011 | US |
Child | 13474004 | US |